Profilo
Thomas L.
Gutshall is the founder of CEPHEID, which was founded in 1996.
He served as Chairman from 2002 to 2013.
Currently, he holds director positions at Profusa, Inc., Pacific Medical Research Foundation, Silver Bullet Therapeutics, Inc., and is an advisor at 1Flourish Capital LLC.
Previously, he served as a Director at CV Therapeutics, Inc. from 1994 to 2009, and as a Director at Metrika, Inc. and Satoris, Inc. He also served as Executive Vice President at Syntex Corp.
from 1989 to 1994.
Mr. Gutshall received his undergraduate degree from the University of Delaware in 1960.
Posizioni attive di Thomas L. Gutshall
| Società | Posizione | Inizio |
|---|---|---|
Pacific Medical Research Foundation | Direttore/Membro del Consiglio | - |
Profusa, Inc. (California)
Profusa, Inc. (California) Electronic Equipment/InstrumentsElectronic Technology Manufactures tissue integrated biosensors for continuous monitoring of body chemistries | Direttore/Membro del Consiglio | 01/01/2012 |
Silver Bullet Therapeutics, Inc.
Silver Bullet Therapeutics, Inc. BiotechnologyHealth Technology Develops antimicrobial coating based on proprietary silver ionization technology for medical devices | Direttore/Membro del Consiglio | - |
1Flourish Capital LLC
1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital invests in companies located in the United States. The firm targets companies operating in the field of the deep technology such as physical AI, defense technology and dual-use innovation sector. It provides financing for pre-seed, seed and early-stage capital requirements. | Consulente / Consigliere | - |
Precedenti posizioni note di Thomas L. Gutshall
| Società | Posizione | Fine |
|---|---|---|
Satoris, Inc.
Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops tests for neurological diseases | Direttore/Membro del Consiglio | 01/01/2011 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Direttore/Membro del Consiglio | 17/04/2009 |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | 01/12/1994 |
Metrika, Inc.
Metrika, Inc. BiotechnologyHealth Technology Manufactures and markets diabetes monitoring products | Direttore/Membro del Consiglio | - |
| CEPHEID | Amministratore Delegato | 22/04/2002 |
Formazione di Thomas L. Gutshall
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
CEPHEID
CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Metrika, Inc.
Metrika, Inc. BiotechnologyHealth Technology Manufactures and markets diabetes monitoring products | Health Technology |
Satoris, Inc.
Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops tests for neurological diseases | Commercial Services |
Profusa, Inc. (California)
Profusa, Inc. (California) Electronic Equipment/InstrumentsElectronic Technology Manufactures tissue integrated biosensors for continuous monitoring of body chemistries | Electronic Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Medical Research Foundation | |
Silver Bullet Therapeutics, Inc.
Silver Bullet Therapeutics, Inc. BiotechnologyHealth Technology Develops antimicrobial coating based on proprietary silver ionization technology for medical devices | Health Technology |
1Flourish Capital LLC
1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital invests in companies located in the United States. The firm targets companies operating in the field of the deep technology such as physical AI, defense technology and dual-use innovation sector. It provides financing for pre-seed, seed and early-stage capital requirements. | Finance |
















